Xilio Therapeutics (XLO) EPS (Basic) (2020 - 2026)
Xilio Therapeutics (XLO) posted EPS (Basic) of -$0.86 for Q1 2026, up 39.09% sequentially from -$1.42 in Q4 2025, and up 66.84% YoY from -$0.52 in Q1 2025.
Xilio Therapeutics (XLO) EPS (Basic) (2020 - 2026) Analysis & Trends
Xilio Therapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$0.86 in Q1 2026.
- Quarterly EPS (Basic) rose 66.84% year-over-year to -$0.86 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.59 (up 75.96% YoY) and the FY2025 annual result came in at -$20.03, up 55.78% from the prior year.
- EPS (Basic) advanced to -$0.86 in Q1 2026 per XLO's latest filing, from -$1.42 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.19 in Q3 2025 and troughed at -$12.69 in Q2 2022.
- A 5-year average of -$6.69 and a median of -$8.85 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 98.21% in 2022, then decreased 10.52% in 2023.
- Over 5 years, EPS (Basic) stood at -$12.48 in 2022, then rose by 25.12% to -$9.35 in 2023, then jumped by 61.06% to -$3.64 in 2024, then soared by 61.01% to -$1.42 in 2025, then soared by 39.09% to -$0.86 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.86, -$1.42, and -$0.19 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Xilio Therapeutics | 177.75 Mn | 41.71 Mn | - | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.22 |
| Mar 31, 2026 | -0.86 |
| Dec 31, 2025 | -1.42 |
| Sep 30, 2025 | -0.19 |
| Jun 30, 2025 | -2.09 |
| Mar 31, 2025 | -2.61 |
| Dec 31, 2024 | -3.64 |
| Sep 30, 2024 | -3.28 |
| Jun 30, 2024 | -3.61 |
| Mar 31, 2024 | -8.93 |
| Dec 31, 2023 | -9.35 |
| Sep 30, 2023 | -8.85 |
| Jun 30, 2023 | -10.29 |
| Mar 31, 2023 | -12.11 |
| Dec 31, 2022 | -12.48 |
| Sep 30, 2022 | -10.44 |
| Jun 30, 2022 | -12.69 |
| Mar 31, 2022 | -10.96 |
| Dec 31, 2021 | -49.08 |
| Sep 30, 2021 | -582.02 |